Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Windtree Therapeutics, Inc. (WINT)

Aptevo Therapeutics Inc. and Windtree Therapeutics, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and Windtree Therapeutics, Inc. are of similar size ($2.4M and $2.3M). Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against −68.4%. Across the 12 metrics below, Aptevo Therapeutics Inc. leads on 7 and Windtree Therapeutics, Inc. on 5.

Valuation

Metric APVO WINT Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 n/m 9.40
P/B 0.25 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 n/m 0.66
EV/Sales (0.37) 63.80 9.02
Earnings yield (4,659.10%) 0.00% (32.88%)
Free cash flow yield (1,718.19%) 0.00% (23.13%)

Profitability

Metric APVO WINT Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) 1,356.23% (51.96%)
Return on assets (186.29%) (210.34%) (46.06%)
Return on invested capital 0.00% (386.34%) 0.00%

Growth

Metric APVO WINT Biotechnology median
Revenue growth (TTM) 92.94% (68.35%) 6.76%
EPS growth (last fiscal year) 99.72% 97.79% 29.88%
Revenue growth, 5-year CAGR (26.64%) (41.28%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO WINT Biotechnology median
Debt to equity 0.00 (1.48) 0.00
Current ratio 2.08 0.33 4.97
Net debt to EBITDA 0.83 0.03 1.01

Dividend

Metric APVO WINT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APVO WINT Biotechnology median
Market cap 2.30m 2.35m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack